Skip Navigation



Carcinogenesis Advance Access published online on July 14, 2008

Carcinogenesis, doi:10.1093/carcin/bgn165
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
29/9/1816    most recent
bgn165v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Nian, H.
Right arrow Articles by Dashwood, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nian, H.
Right arrow Articles by Dashwood, R. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter

Hui Nian1, Barbara Delage1, John T. Pinto2 and Roderick H. Dashwood1

1 Linus Pauling Institute, Oregon State University, Corvallis, OR
2 Dept of Biochemistry & Molecular Biology, New York Medical College, Valhalla, New York

Corresponding author: Dr. Roderick H. Dashwood, Linus Pauling Institute, Oregon State University, 571 Weniger Hall, Corvallis, OR 97331-6512, USA; Tel: (541) 737-5086; Fax: (541) 737-5077; E-mail: rod.dashwood{at}oregonstate.edu

Histone deacetylase (HDAC) inhibitors have the potential to de-repress epigenetically-silenced genes in cancer cells, leading to cell cycle arrest and apoptosis. In the present study, we screened several garlic-derived small organosulfur compounds for their ability to inhibit HDAC activity in vitro. Among the organosulfur compounds examined, allyl mercaptan (AM) was the most potent HDAC inhibitor. Molecular modeling, structure-activity, and enzyme kinetics studies with purified human HDAC8 provided evidence for a competitive mechanism (Ki = 24 µM AM). In AM-treated human colon cancer cells, HDAC inhibition was accompanied by a rapid and sustained accumulation of acetylated histones in total cellular chromatin. Chromatin immunoprecipitation assays confirmed the presence of hyperacetylated histone H3 on the P21WAF1 gene promoter within 4 hr of AM exposure, and there was increased binding of the transcription factor Sp3. At a later time, 24 hr after AM treatment, there was enhanced binding of p53 in the distal enhancer region of the P21WAF1 gene promoter. These findings suggest a primary role for Sp3 in driving P21 gene expression after HDAC inhibition by AM, followed by the subsequent recruitment of p53. Induction of p21Waf1 protein expression was detected at time-points between 3 and 72 hours after AM treatment, and coincided with growth arrest in G1 of the cell cycle. The results are discussed in the context of other anti-carcinogenic mechanisms ascribed to garlic organosulfur compounds, and the metabolic conversion of such compounds to potential HDAC inhibitors in situ.

Received February 19, 2008; revised July 7, 2008; accepted July 8, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
L. Escoubet-Lozach, I-L. Lin, K. Jensen-Pergakes, H. A. Brady, A. K. Gandhi, P. H. Schafer, G. W. Muller, P. J. Worland, K. W.H. Chan, and D. Verhelle
Pomalidomide and Lenalidomide Induce p21WAF-1 Expression in Both Lymphoma and Multiple Myeloma through a LSD1-Mediated Epigenetic Mechanism
Cancer Res., September 15, 2009; 69(18): 7347 - 7356.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Nian, W. H. Bisson, W.-M. Dashwood, J. T. Pinto, and R. H. Dashwood
{alpha}-Keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cells
Carcinogenesis, August 1, 2009; 30(8): 1416 - 1423.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
J.-I. Lee, H. Nian, A. J.L. Cooper, R. Sinha, J. Dai, W. H. Bisson, R. H. Dashwood, and J. T. Pinto
{alpha}-Keto Acid Metabolites of Naturally Occurring Organoselenium Compounds as Inhibitors of Histone Deacetylase in Human Prostate Cancer Cells
Cancer Prevention Research, July 1, 2009; 2(7): 683 - 693.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.